New Partnership Creates an Automated Anatomic Pathology Slide-Scanning Solution
WALTHAM, Mass., (October 12, 2022)—Sakura Finetek, a global leader in histopathology products and Evident Scientific, a wholly owned subsidiary of Olympus Corporation, and a global leader in microscopy and imaging solutions, today announced a collaboration to offer a full workflow solution for anatomic pathology slide preparation and high-resolution digital scanning in the Americas.
The collaboration between the companies initially began with a project related to H&E staining characteristics using the special optical configuration options of the VS200 slide scanner. Now, they have formally joined together to offer an automated solution that enables users to generate the high-resolution images needed for digital slide review and image analysis while reducing turnaround time.
The VS200 slide scanner captures high-quality virtual slide images and offers flexibility to empower advanced quantitative image analysis for brain, cancer and stem cell research as well as drug discovery. Simple to use, the VS200 system offers intuitive workflows that enable users to start scanning a slide in as few as two clicks. Efficient and reliable stain assessments are facilitated by its 400x magnification capacity. The VS200 system is also adaptable to meet current needs and expandable for future research requirements. Scientists can see more of their slides in less time with the system’s lineup of flexible features.
Sakura Finetek provides first-in-class automation enabling the production of reproducible high-quality blocks, slides, and digital images. Sakura Finetek customers can now acquire an Olympus SLIDEVIEW™ VS200 digital scanner at the same time they invest in automating their histopathology and immunohistochemistry processes, via reagent rental, leases or capital purchases. This partnership is a major step in Sakura Finetek’s vision of becoming the first company that achieves full pathology automation by providing integrated solutions.
“We look forward to this technology enabling us to produce more experiments that demonstrate the benefits and values of this end-to-end automated workflow. Increasing the level of histopathology automation to reduce turnaround time while increasing quality has been a goal of Sakura Finetek since our founding in 1870. Partnering with one of the world’s leading companies in microscopy and imaging will only serve to better reach that goal resulting ultimately in better patient care.”—Patrick Devor, Vice President of Sales at Sakura Finetek USA, Inc.
“Sakura Finetek’s mission to advance cancer diagnostics by providing innovative and high-quality integrated solutions for anatomic pathology and patients aligns with Evident's mission to help make people’s lives healthier, safer and more fulfilling. This collaboration solidifies our commitment to ensuring histology and pathology labs have solutions, from tissue preparation to digital pathology. It enables our customers to achieve greater slide preparation and scanning efficiencies within an integrated pathology experience.”—Lee Wagstaff, Vice President of Life Science Sales and Marketing at Evident Americas.
At Evident, we are guided by the scientific spirit—innovation and exploration are at the heart of what we do. Committed to making people’s lives healthier, safer and more fulfilling, we support our customers with solutions that solve their challenges and advance their work; whether it’s researching medical breakthroughs, inspecting infrastructure, or exposing hidden toxins in consumer products.
Evident Life Science empowers scientists and researchers through collaboration and cutting-edge life science solutions. Dedicated to meeting the challenges and supporting the evolving needs of its customers, Evident Life Science advances a comprehensive range of microscopes for pathology, hematology, IVF, and other clinical applications as well as for research and education.
For more information, visit EvidentScientific.com.
About Sakura Finetek USA
With its US office based in Torrance, California, Sakura Finetek is the global leader in advancing cancer diagnostics by providing integrated solutions for anatomic pathology and patient treatment through best-in-class innovation, quality and customer care. With a strategic focus on end-to-end automation, Sakura Finetek continues to lead the industry in the development and commercialization of automated histopathology instrumentation and consumables for anatomic pathology. Sakura Finetek systems dramatically increase efficiency, standardize results and enable clinical laboratories to more simply manage their daily workload while significantly impacting patient care.
For more information, visit www.sakuraus.com/.
Erico von Bueren
Sr. Director of Marketing and Strategy
Sakura Finetek USA, Inc.
1750 W. 214th St.
Torrance, CA 90501
# # #
SLIDEVIEW is a trademark of Evident Corporation or its subsidiaries.